Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR buy BlueGraySphere

Start price
€92.40
26.02.21 / 30%
Target price
€150.00
26.02.22
Performance (%)
40.64%
End price
€129.95
27.02.22
Summary
This prediction ended on 27.02.22 with a price of €129.95. The BUY prediction by BlueGraySphere for BioNTech SE ADR saw massive gains of 40.64%. BlueGraySphere has 30% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to BlueGraySphere what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Market Leader or Top 3
Very small cyclical dependencies
Very Future proof/growth oriented business model
Leading role in innovation
Could be very worthwhile Investment >20% year
Well known brand
Cons
High risks for its business
Dependend from few customers or products

Comments by BlueGraySphere for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) 40.64%
Target price 150.000
Change
Ends at

Buy mit Kursziel 150,0

In the thread Trading Biontech SE
Prediction Buy
Perf. (%) 40.64%
Target price 150.000
Change
Ends at 26.02.22

Die von BlueGraySphere gewählte maximale Laufzeit wurde überschritten